These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24205307)

  • 1. Influence of Atg5 mutation in SLE depends on functional IL-10 genotype.
    López P; Alonso-Pérez E; Rodríguez-Carrio J; Suárez A
    PLoS One; 2013; 8(10):e78756. PubMed ID: 24205307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypes.
    Ciccacci C; Perricone C; Alessandri C; Latini A; Politi C; Delunardo F; Pierdominici M; Conti F; Novelli G; Ortona E; Borgiani P
    Lupus; 2018 Aug; 27(9):1464-1469. PubMed ID: 29759048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of autophagy-related genes in Egyptian systemic lupus erythematosus patients.
    Kamel AM; Badary MS; Mohamed WA; Ahmed GH; El-Feky MA
    Int J Rheum Dis; 2020 Aug; 23(9):1226-1232. PubMed ID: 32783391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus.
    Kariuki SN; Crow MK; Niewold TB
    Arthritis Rheum; 2008 Sep; 58(9):2818-23. PubMed ID: 18759295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus.
    Suárez A; López P; Mozo L; Gutiérrez C
    Ann Rheum Dis; 2005 Nov; 64(11):1605-10. PubMed ID: 15800006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs.
    López P; Gómez J; Mozo L; Gutiérrez C; Suárez A
    Arthritis Res Ther; 2006; 8(2):R42. PubMed ID: 16507146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population.
    Mohammadi S; Saghaeian Jazi M; Zare Ebrahimabad M; Eghbalpour F; Abdolahi N; Tabarraei A; Yazdani Y
    Int J Immunogenet; 2019 Feb; 46(1):20-30. PubMed ID: 30430731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of interleukin 6 and interleukin 10 in Egyptian patients with systemic lupus eythematosus.
    Talaat RM; Alrefaey SA; Bassyouni IH; Ashour ME; Raouf AA
    Lupus; 2016 Mar; 25(3):255-64. PubMed ID: 26568585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-α and a C-reactive protein gene variant.
    Enocsson H; Sjöwall C; Kastbom A; Skogh T; Eloranta ML; Rönnblom L; Wetterö J
    Arthritis Rheumatol; 2014 Jun; 66(6):1568-73. PubMed ID: 24574329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients.
    Mousa TG; Omar HH; Emad R; Salama MI; Omar W; Fawzy M; Hassoba HM
    Clin Rheumatol; 2019 Mar; 38(3):777-784. PubMed ID: 30374748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus.
    Guarnizo-Zuccardi P; Lopez Y; Giraldo M; Garcia N; Rodriguez L; Ramirez L; Uribe O; Garcia L; Vasquez G
    Tissue Antigens; 2007 Nov; 70(5):376-82. PubMed ID: 17711410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
    Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
    Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of ATG5 Gene Polymorphisms With Behçet's Disease and ATG10 Gene Polymorphisms With VKH Syndrome in a Chinese Han Population.
    Zheng M; Yu H; Zhang L; Li H; Liu Y; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8280-7. PubMed ID: 26747760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P; Gómez J; Prado C; Gutiérrez C; Suárez A
    J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.
    Salloum R; Franek BS; Kariuki SN; Rhee L; Mikolaitis RA; Jolly M; Utset TO; Niewold TB
    Arthritis Rheum; 2010 Feb; 62(2):553-61. PubMed ID: 20112359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare Variants of ATG5 Are Likely to Be Associated With Chinese Patients With Systemic Lupus Erythematosus.
    Zhang YM; Cheng FJ; Zhou XJ; Qi YY; Zhao MH; Zhang H
    Medicine (Baltimore); 2015 Jun; 94(22):e939. PubMed ID: 26039132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between PPP2CA polymorphisms and clinical features in southwest Chinese systemic lupus erythematosus patients.
    Zhang J; Meng Y; Wu H; Wu Y; Yang B; Wang L
    Medicine (Baltimore); 2018 Jul; 97(27):e11451. PubMed ID: 29979448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ribosomal P antibodies are associated with elevated circulating IFNα and IL-10 levels in systemic lupus erythematosus patients.
    Mozo L; López P; Caminal-Montero L; Rodríguez-Carrio J; Suárez A
    Lupus; 2014 Dec; 23(14):1477-85. PubMed ID: 25107939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of extended interleukin-10 promoter haplotypes with disease susceptibility and manifestations in German patients with systemic lupus erythematosus.
    Schotte H; Willeke P; Becker H; Poggemeyer J; Gaubitz M; Schmidt H; Schlüter B
    Lupus; 2014 Apr; 23(4):378-85. PubMed ID: 24536045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of interleukin-21 polymorphisms with interleukin-21 serum levels and risk of systemic lupus erythematosus.
    Lan Y; Luo B; Wang JL; Jiang YW; Wei YS
    Gene; 2014 Mar; 538(1):94-8. PubMed ID: 24434811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.